The Company has a two-tier board structure consisting of a Management Board and a Supervisory Board. The Management Board is responsible for the day-to-day management which includes, among other things, formulating strategies and policies, and setting and achieving the Company’s objectives. The Supervisory Board supervises and advises the Management Board.
These two corporate bodies are subject to Dutch law and regulated by the Company’s Articles of Association as well as by the Dutch Corporate Governance Code. The Company makes every effort to comply with the Dutch Corporate Governance Code. Where this is not possible, exceptions to the Code are explained in full in its annual report according to the ‘comply or explain’ rule.
Deed of Amendment of the Articles of Association dated 9 April 2019. This amendment has not yet entered into force and shall only enter into force if and when a copy of this deed is filed by the company with the trade register of the Dutch Chamber of Commerce.
Articles of Association (English)
Articles of Association (Dutch)
Insider Trading Policy
Management Board Rules
Supervisory Board Rules
Charter of Supervisory Board Audit Committee
Charter of Supervisory Board Nomination and Remuneration Committee
Code of Conduct
Policy on Bilateral Contacts
Policy on Ownership and Transactions of Non-Kiadis Securities
Kiadis Pharma N.V. Prospectus 16 June 2015
Composition and Rotation Schedule